The International Classification of Headache Disorders, 3rd edition (beta version).
Headache Classification Committee of the International Headache Society (IHS)
https://pubmed.ncbi.nlm.nih.gov/23771276Actively Recruiting
Led by The University of Texas Health Science Center, Houston · Updated on 2026-02-18
1500
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are conducting a national, prospective, multicenter observational study at the Will Erwin Headache Research Center focused on patients with Cluster Headache and Trigeminal Neuralgia. This study also includes similar conditions such as other trigeminal autonomic cephalalgias (TACs) like paroxysmal hemicrania, SUNCT, SUNA, and hemicrania continua. The goal is to create a detailed registry that categorizes patients by condition type, severity, symptoms, and related medical or psychological issues including depression and disability. Participants include patients diagnosed with these headache disorders as well as healthy volunteer controls and family members, who may be enrolled to help identify genetic mutations. Each enrolled participant undergoes comprehensive evaluations including genomic and epigenomic studies, collection of past medical history, imaging reports, and physical exams. This registry aims to support matching patients with appropriate interventional clinical trials in the future. During the study, participants will be assessed with several scales including the HIT-6 for headache impact, the morningness-eveningness scale, and the GAD-7 for anxiety, all over an average of five years. Genetic and molecular biomarkers will also be collected and monitored throughout this period. This long-term observational study continues through its completion, providing ongoing data on the studied conditions and patient characteristics.
CONDITIONS
The Will Erwin Headache Research Center - Cluster Headache Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Initial assessment period
Participants undergo detailed evaluations including genomic and epigenomic studies, past medical history review, imaging reports, and physical exams to classify their condition.
1 to 2 visits depending on assessments
Duration - Approximately 5 years
Participants are followed over time with assessments using various scales and biomarker measurements to observe their condition.
Periodic visits for assessments throughout the study duration
Total: 1 location
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
R
Rebecca Martinez, RN
M
Mark J Burish, MD, PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Headache Classification Committee of the International Headache Society (IHS)
https://pubmed.ncbi.nlm.nih.gov/23771276